If You Invested in Silverback Therapeutics Inc (SBTX)
See the SBTX overviewWhat $1,000 or $10,000 in SBTX Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Dec 4, 2020 |
|---|---|---|---|---|
| $1,000 | $667 -33% | — | — | $235 -77% |
| $10,000 | $6,670 -33% | — | — | $2,348 -77% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2022-11-08. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for SBTX$1,000 Investment Over Time
SBTX vs S&P 500Year-by-Year Returns
SBTX annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2020Dec 4, 2020 to Dec 31, 2020 | $25.00 | $46.34 | +85.4% | +85.4% |
| 2021 | $46.34 | $6.66 | -85.6% | -73.4% |
| 2022Dec 31, 2021 to Nov 8, 2022 | $6.66 | $5.87 | -11.9% | -76.5% |
About Silverback Therapeutics Inc
Frequently Asked Questions
Silverback Therapeutics Inc investment returns
How much was $1,000 invested in Silverback Therapeutics Inc worth at its last close?
If you invested $1,000 in Silverback Therapeutics Inc (SBTX) 1 year before its last close, on 2021-11-08, your investment was worth $667 on 2022-11-08, a -33.3% price return without dividends, growing at a compounded rate of -33.3% per year (CAGR).
Has Silverback Therapeutics Inc outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare SBTX performance over available time periods.
What is Silverback Therapeutics Inc's average annual return?
The compound annual growth rate (CAGR) of SBTX’s share price over the 1 year to Nov 8, 2022 is -33.3%, without dividends. Individual years vary a great deal, and SBTX’s best recent full year was 2021 (-85.6%) while the worst was 2021 (-85.6%).
For informational and educational purposes only, not investment advice.
